Conferencia impartida por David Fairen-Jimenez (Adsorption & Advanced Materials Laboratory (A2ML), Department of Chemical Engineering & Biotechnology, University of Cambridge, UK)
Perfil del Dr David Fairen-Jimenez: David Fairen-Jimenez is a Royal Society University Research Fellow and Reader in Molecular Engineering in the Department of Chemical Engineering & Biotechnology at the University of Cambridge, where he leads the Adsorption & Advanced Material Laboratory (AAML). His research into the application of metal-organic frameworks (MOFs) in energy applications and nanoscale drug delivery is underpinned by fundamental studies into molecular recognition and self-assembly processes inside nanoporous materials. His expertise has been built through integrated research which combines 1) synthesis and engineering of novel nanomaterials, 2) molecular modelling, 3) drug delivery processes for cancer treatment, and 4) sustainable industrial applications. He leads a multidisciplinary team of 32 researchers, including 16 PhD, 3 MPhil and 4 ChemE Master students as well as 9 post-docs.
He graduated with a PhD in porous materials in chemistry, under the supervision of Prof Carlos Moreno-Castilla, from the University of Granada in 2006. He then worked with Prof. Tina Duren at the University of Edinburgh, studying adsorption in metal-organic frameworks combining advanced experimental techniques molecular and modelling for the design of novel functional materials. He expanded his research at Northwestern University (USA), working with some of the strongest international leaders in his field, including Profs. Randall Snurr, J. Hupp, O. Farha, and F. Stoddart, and implementing new computational methods for H2 storage and toxic industrial compounds capture. He returned to UK as a Royal Society University Research Fellow in Cambridge in late 2012, to initiate his independent career.
To date, David has published 84 papers and filed 7 patents (citations, 4650+; h-index, 35) and has given many invited seminars and lectures at conferences and universities around the world. He is also a founder and Director at Immaterial Labs Ltd., a MOF manufacturing company for gas storage and air filtration, and Tarsis Technologies Ltd., a company for slower and controlled delivery of drugs using amorphous MOFs. In 2016, he was awarded a European Research Council (ERC) Consolidator Grant for the “Design of NanoMOFs Capsules for Drug Delivery and Bioimaging” in cancer diagnosis and therapy. Overall, David has raised £17M in multiple projects. He has extensive experience of collaborations with industry, having led current and past projects with Shell, BP and Astra Zeneca.»
- Fecha: Viernes 22 de noviembre de 2019
- Lugar: Sala Eniac del Edificio Mecenas, Facultad de Ciencias de la Universidad de Granada
- Horario: 10:00 h
- Organiza: Departamento de Química Inorgánica. Unidad de Excelencia de Química Aplicada a Biomedicina y Medioambiente.
- Más información:
Prof. Jorge A. Rodriguez Navarro
Departamento de Química Inorgánica
Universidad de Granada
Av. Fuentenueva S/N, 18071 Granada
Tel: +34-958 248093; Fax: +34-958 248526
E-mail: jarn@ugr.es